Published in Nutrients on September 15, 2016
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med (2009) 7.45
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet (2007) 7.11
Inflammation and colon cancer. Gastroenterology (2010) 6.32
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res (2011) 5.97
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res (2011) 5.58
Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science (2007) 5.54
Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther (2007) 5.47
Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg (2009) 5.38
Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology (2004) 4.89
Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett (2009) 3.48
Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer (2007) 3.45
Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe (2013) 3.21
Primary prevention of colorectal cancer. Gastroenterology (2010) 3.20
Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A (2010) 3.18
Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J (2011) 2.92
Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One (2011) 2.84
Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One (2012) 2.77
Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology (2007) 2.73
Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes (2010) 2.70
Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal (2013) 2.59
A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol (2012) 2.56
Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med (2006) 2.48
Towards the human colorectal cancer microbiome. PLoS One (2011) 2.30
Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe (2013) 2.22
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A (2014) 2.22
Fusobacterium is associated with colorectal adenomas. PLoS One (2013) 1.99
Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut (2000) 1.99
Oxidative stress and cancer: an overview. Ageing Res Rev (2012) 1.93
The gut microbiota and host health: a new clinical frontier. Gut (2015) 1.91
Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov (2009) 1.89
Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis (2002) 1.76
Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene (2009) 1.64
Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One (2013) 1.62
Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J (2012) 1.54
Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. J Infect Dis (2010) 1.53
Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol (2008) 1.45
A prospective cohort study on the relation between meat consumption and the risk of colon cancer. Cancer Res (1994) 1.40
Fruit and vegetable consumption and colorectal adenomas in the Nurses' Health Study. Cancer Res (2006) 1.39
Inorganic arsenic in rice bran and its products are an order of magnitude higher than in bulk grain. Environ Sci Technol (2008) 1.29
Diet and supplements and their impact on colorectal cancer. J Gastrointest Oncol (2013) 1.27
Augmented production of extracellular superoxide by blood isolates of Enterococcus faecalis. J Infect Dis (1996) 1.27
Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat Res (2009) 1.27
Interleukin-17 and innate immunity in infections and chronic inflammation. J Autoimmun (2015) 1.22
Human gut microbiome: the second genome of human body. Protein Cell (2010) 1.20
Helicobacter typhlonius sp. nov., a Novel Murine Urease-Negative Helicobacter Species. J Clin Microbiol (2001) 1.17
A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. Br J Nutr (2012) 1.14
Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8. Mol Cancer (2010) 1.12
Case-control study of proximal and distal colon cancer and diet in Wisconsin. Int J Cancer (1988) 1.12
Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis (1998) 1.12
The impact of antibiotics on the gut microbiota as revealed by high throughput DNA sequencing. Discov Med (2012) 1.08
Inhibitory effect of cycloartenol ferulate, a component of rice bran, on tumor promotion in two-stage carcinogenesis in mouse skin. Biol Pharm Bull (1998) 1.06
Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J Gastroenterol (2014) 1.06
Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer. PLoS One (2014) 1.05
Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention. World J Gastrointest Oncol (2014) 1.05
Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol (2014) 1.04
Microbiota disbiosis is associated with colorectal cancer. Front Microbiol (2015) 1.02
Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis. Clin Exp Gastroenterol (2008) 1.02
The role of inflammation in colon cancer. Adv Exp Med Biol (2014) 1.01
Chemopreventive properties of dietary rice bran: current status and future prospects. Adv Nutr (2012) 1.00
Dietary meat, endogenous nitrosation and colorectal cancer. Biochem Soc Trans (2007) 0.92
Colon Macrophages Polarized by Commensal Bacteria Cause Colitis and Cancer through the Bystander Effect. Transl Oncol (2013) 0.91
New prebiotics from rice bran ameliorate inflammation in murine colitis models through the modulation of intestinal homeostasis and the mucosal immune system. Scand J Gastroenterol (2010) 0.90
Emerging roles of lactic acid bacteria in protection against colorectal cancer. World J Gastroenterol (2014) 0.89
Consumption of rice bran increases mucosal immunoglobulin A concentrations and numbers of intestinal Lactobacillus spp. J Med Food (2012) 0.89
An overview of global rice production, supply, trade, and consumption. Ann N Y Acad Sci (2014) 0.88
β-sitosterol prevents lipid peroxidation and improves antioxidant status and histoarchitecture in rats with 1,2-dimethylhydrazine-induced colon cancer. J Med Food (2012) 0.86
Dietary rice bran promotes resistance to Salmonella enterica serovar Typhimurium colonization in mice. BMC Microbiol (2012) 0.86
Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembronic antigen induces mucosal and systemic immunity and prevents progression of colorectal cancer. J Immunol (2008) 0.86
Pilot dietary intervention with heat-stabilized rice bran modulates stool microbiota and metabolites in healthy adults. Nutrients (2015) 0.86
Colon cancer in inflammatory bowel disease: recent trends, questions and answers. Gastroenterol Clin Biol (2009) 0.83
High protective efficacy of rice bran against human rotavirus diarrhea via enhancing probiotic growth, gut barrier function, and innate immunity. Sci Rep (2015) 0.83
Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice. Carcinogenesis (2015) 0.82
Impact of antibiotic exposure on the risk of colorectal cancer. Pharmacoepidemiol Drug Saf (2015) 0.81
Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment. Oncotarget (2015) 0.80
Frequent Use of Antibiotics Is Associated with Colorectal Cancer Risk: Results of a Nested Case-Control Study. Dig Dis Sci (2015) 0.78
Immunomodulatory effects of feruloylated oligosaccharides from rice bran. Food Chem (2012) 0.78
Dietary supplementation with rice bran or navy bean alters gut bacterial metabolism in colorectal cancer survivors. Mol Nutr Food Res (2016) 0.77
Effects of rice bran oil on the intestinal microbiota and metabolism of isoflavones in adult mice. Int J Mol Sci (2012) 0.77
Effects of Lactobacillus salivarius Ren on cancer prevention and intestinal microbiota in 1, 2-dimethylhydrazine-induced rat model. J Microbiol (2015) 0.77
Probiotics Clostridium butyricum and Bacillus subtilis ameliorate intestinal tumorigenesis. Future Microbiol (2015) 0.76
Protective effect of p-methoxycinnamic acid, an active phenolic acid against 1,2-dimethylhydrazine-induced colon carcinogenesis: modulating biotransforming bacterial enzymes and xenobiotic metabolizing enzymes. Mol Cell Biochem (2014) 0.76
The Utilization of the Immune System in Lung Cancer Treatment: Beyond Chemotherapy. Int J Mol Sci (2016) 0.79